S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway

被引:13
|
作者
Zheng, Susu [1 ,2 ]
Shen, Hujia [1 ,2 ]
Jia, Qingan [1 ,2 ]
Jing, Chuyu [1 ,2 ]
Lin, Jiajia [1 ,2 ]
Zhang, Meixia [1 ,2 ]
Zhang, Xiaolei [3 ]
Zhang, Boheng [1 ,2 ]
Liu, Yinkun [1 ,2 ]
机构
[1] Fudan Univ, Liver Canc Inst, Dept Hepat Oncol, Shanghai 20032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai 20032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 20032, Peoples R China
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; prognosis; proliferation; S100A6; HUMAN HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; THERAPEUTIC TARGET; MAPK PATHWAYS; EXPRESSION; PROTEIN; KINASE; CALCYCLIN; MIGRATION; GROWTH;
D O I
10.2217/fon-2017-0199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: We explored the expression of S100A6 and its role in intrahepatic cholangiocarcinoma (ICC). Methods: The expression of S100A6 in ICC samples was detected by immunohistochemistry. In vitro experiments, we silenced and overexpressed S100A6 to investigate its role in cell functions. Results: The expression of S100A6 was markedly increased in ICC tissues and cell lines. S100A6 overexpression was an independent risk factor for patients' survival. Silencing S100A6 resulted in a suppression of proliferation and p38/MAPK activity, while overexpressing S100A6 caused a promotion of proliferation and p38/MAPK. Discussion: S100A6 participated in the proliferation of ICC cells and correlated with a more aggressive behavior of ICC. Conclusion: S100A6 may serve as a novel prognostic marker and a potential therapeutic target for ICC patients.
引用
收藏
页码:2053 / 2063
页数:11
相关论文
共 50 条
  • [31] Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy
    Slone, Samuel
    Anthony, Sarah R.
    Wu, Xiaoqing
    Benoit, Joshua B.
    Aube, Jeffrey
    Xu, Liang
    Tranter, Michael
    CELLULAR SIGNALLING, 2016, 28 (11) : 1735 - 1741
  • [32] Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway
    Wu, Xiaoling
    Zhou, Jie
    Cai, Dongge
    Li, Mu
    ONCOLOGY REPORTS, 2017, 38 (02) : 1312 - 1320
  • [33] Activation of spinal PDGFRβ in microglia promotes neuronal autophagy via p38 MAPK pathway in morphine-tolerant rats
    Jia, Xiaoqian
    Zhang, Anqi
    Li, Zheng
    Peng, Xiaoling
    Tian, Xuebi
    Gao, Feng
    JOURNAL OF NEUROCHEMISTRY, 2021, 158 (02) : 373 - 390
  • [34] Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway
    Huang, Ren-hong
    Quan, Ying-jun
    Chen, Jin-hong
    Wang, Ting-feng
    Xu, Ming
    Ye, Min
    Yuan, Hao
    Zhang, Chong-jie
    Liu, Xiao-jian
    Min, Zhi-jun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (05) : 1851 - 1864
  • [35] Netrin-1 induces the proliferation of gastric cancer cells via the ERK/MAPK signaling pathway and FAK activation
    Yin, Kai
    Shang, Mengyuan
    Dang, Shengchun
    Wang, Linjun
    Xia, Yiwen
    Cui, Lei
    Fan, Xin
    Qu, Jianguo
    Chen, Jixiang
    Xu, Zekuan
    ONCOLOGY REPORTS, 2018, 40 (04) : 2325 - 2333
  • [36] Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype
    Li, Mengya
    Liu, Yu
    Liu, Yajun
    Yang, Lu
    Xu, Yan
    Wang, Weiqiong
    Jiang, Zhongxing
    Liu, Yanfang
    Wang, Shujuan
    Wang, Chong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway
    Zaparte, Aline
    Cappellari, Angelica R.
    Brandao, Caroline A.
    de Souza, Julia B.
    Borges, Thiago J.
    Kist, Luiza W.
    Bogo, Mauricio R.
    Zerbini, Luiz F.
    Ribeiro Pinto, Luis Felipe
    Glaser, Talita
    Goncalves, Maria Carolina B.
    Naaldijk, Yahaira
    Ulrich, Henning
    Morrone, Fernanda B.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 891
  • [38] Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway
    Yong, Lei
    Ma, Yunlong
    Zhu, Bin
    Liu, Xiao
    Wang, Peng
    Liang, Chen
    He, Guanping
    Zhao, Zhigang
    Liu, Zhongjun
    Liu, Xiaoguang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (06) : 1009 - 1020
  • [39] Absent in melanoma 2 attenuates proliferation and migration and promotes apoptosis of human colorectal cancer cells by activating P38MAPK signaling pathway
    Zhang, Zhi
    Li, Xiaosong
    Zhang, Ying
    Zhu, Hao
    Qiao, Zhenguo
    Lu, Yang
    Mi, Xiuwei
    Cao, Huihua
    Shen, Genhai
    He, Songbing
    ONCOLOGY RESEARCH, 2024, 32 (02) : 353 - 360
  • [40] Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3
    Li, Jun
    Ren, Siyang
    Liu, Yongjian
    Lian, Zhigang
    Dong, Bin
    Yao, Yiqun
    Xu, Yinghui
    JOURNAL OF NEURO-ONCOLOGY, 2017, 132 (01) : 15 - 26